Using data from GEO and TCGA, we employed the Kaplan–Meier plotter, which revealed that STC2 prognostic significance in breast cancer is dependent on ER status: The results showed that high STC2 expression was associated with favorable outcomes in ER-positive cases but was linked to poorer prognosis in ER-negative cases. Here, STC2 is linked to breast cancer.